Under oxaliplatin treatment, knockdown of PiHL in resistant CRC cells reduced cell viability, induced cell apoptosis, and inhibited colony formation and cell proliferation (Figs. 3C–F and S3F, G). This evidence concerns the gene PCAT1 and colorectal carcinoma.